Introduction – Objectives:As brain–computer interfaces (BCIs) transition from experimental applications toward broader clinical and commercial deployment, global health systems face the challenge of ensuring that innovation advances without compromising long-term brain health, human rights, and equitable access. While millions of people worldwide live with neurological conditions that may benefit from neurotechnologies, evidence regarding the long-term neurological, psychosocial, and societal impacts of sustained BCI use remains limited. Existing governance initiatives, including the World Health Organization’s work on digital health and medical devices, the OECD Recommendation on Responsible Innovation in Neurotechnology (2019), and the UNESCO Recommendation on the Ethics of Neurotechnology (2025), provide important ethical and regulatory foundations but require integration into a coordinated global health policy approach. This study proposes a Global Collaborative Policy Framework for Brain Health Governance that connects international organizations, public health authorities, healthcare providers, academic institutions, industry, civil society, and contemplative health organizations to strengthen prevention, preparedness, community participation, and long-term health protection throughout the BCI lifecycle. Methodology:This study conducted a multidisciplinary policy analysis of international governance instruments, regulatory frameworks, and scientific literature published between 2019 and 2026 concerning neurotechnology, medical device governance, brain health, public health systems, and global health policy. Comparative analysis was undertaken to identify actionable governance mechanisms, define stakeholder responsibilities, and develop a policy framework capable of linking technological innovation with health-system readiness, community engagement, and longitudinal monitoring. Results and Discussion:The proposed policy framework is structured around four interconnected pillars:(1) Global brain-health surveillance and preparedness mechanisms to establish international monitoring systems for long-term neurological, cognitive, and psychosocial outcomes among BCI users and to support evidence-based public-health responses;(2) Harmonized regulatory and safety governance to strengthen standards for device development, clinical implementation, informed consent, post-market evaluation, and equitable access across different healthcare contexts;(3) Integrated research and knowledge systems combining neuroscience, public health, behavioral science, ethics, and health policy to identify indicators of neurological safety, resilience, and quality of life; and(4) Community-centred partnerships for brain-health promotion involving civil society and contemplative health organizations with expertise in stress reduction, health promotion, and community engagement to support public education, ethical dialogue, culturally appropriate outreach, and sustained participation in longitudinal health initiatives. Conclusions:The emergence of BCIs requires a shift from reactive technology regulation toward proactive global health governance. This proposed collaborative policy framework offers a practical pathway for international cooperation by integrating scientific evidence, ethical oversight, health-system preparedness, and community participation. By embedding brain-health protection within global health policy, responsible innovation can be advanced while promoting equity, resilience, and sustainable neurological well-being in diverse populations.
No takes yet. Share an insight, caveat, or question.
Ya-Ning Chang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: